The second mesothelioma report, launched today by RCP London, demonstrates improvement in the number of people diagnosed with malignant pleural mesothelioma (MPM) surviving for more than 1 year*.

The RCP has joined the Alliance to Save our Antibiotics, which represents organisations from across Europe spanning the health, medical, and environmental sectors.